3.5200
-0.0100
(-0.28%)
At close: April 15 at 4:00:02 PM EDT
3.5100
-0.01
(-0.28%)
After hours: April 15 at 5:14:51 PM EDT
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 1.59M | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
KEYSER DONALD JEFFREY PH.D Director | Conversion of Exercise of derivative security at price 4.42 per share. | Direct | 16,937 | Jul 24, 2024 |
KREIS LESLIE W JR Beneficial Owner of more than 10% of a Class of Security | Sale at price 6.25 - 6.33 per share. | Indirect | 189,100 | May 24, 2024 |
KREIS LESLIE W JR Beneficial Owner of more than 10% of a Class of Security | Sale at price 4.40 - 4.87 per share. | Indirect | 676,294 | Feb 29, 2024 |
FLETCHER AARON G.L. Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security at price 3.13 per share. | Indirect | 247,336 | Jan 17, 2024 |
KREIS LESLIE W JR Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security at price 3.13 per share. | Indirect | 247,336 | Jan 17, 2024 |
FLETCHER AARON G.L. Beneficial Owner of more than 10% of a Class of Security | Sale at price 4.20 per share. | Indirect | 247,334 | Jan 17, 2024 |
KREIS LESLIE W JR Beneficial Owner of more than 10% of a Class of Security | Sale at price 4.20 per share. | Indirect | 247,334 | Jan 17, 2024 |
FLETCHER AARON G.L. Beneficial Owner of more than 10% of a Class of Security | Sale at price 3.44 per share. | Indirect | 499,997 | Nov 29, 2023 |
KREIS LESLIE W JR Beneficial Owner of more than 10% of a Class of Security | Sale at price 3.44 per share. | Indirect | 499,997 | Nov 29, 2023 |
Related Tickers
ACTU Actuate Therapeutics, Inc. Common stock
7.95
-0.63%
RNTX Rein Therapeutics Inc.
1.7200
+3.61%
INAB IN8bio, Inc.
0.1632
+2.51%
EPRX Eupraxia Pharmaceuticals Inc.
3.3450
+7.90%
CELZ Creative Medical Technology Holdings, Inc.
2.0500
-4.21%
FULC Fulcrum Therapeutics, Inc.
3.0400
+4.11%
LPTX Leap Therapeutics, Inc.
0.3743
+9.77%
GOSS Gossamer Bio, Inc.
0.8299
+2.09%
ALZN Alzamend Neuro, Inc.
0.7600
-3.68%
IDYA IDEAYA Biosciences, Inc.
16.98
-0.76%